Press Release: Odyssey : Odyssey Therapeutics and Terray Therapeutics Enter Strategic Collaboration to Jointly Discover and Develop First-in-Class Transcription Factor Therapies
BOSTON & LOS ANGELES--(BUSINESS WIRE)-- #Biotech--Odyssey and Terray entered into a collaboration to discover and develop small molecule medicines against transcription factor targets of interest.
Read full article »
Odyssey is a Massachusetts-based biotechnology company that researches and develops immunomodulators and oncology medicines for the treatment of inflammatory diseases.
Read more